Who Paid My Doc Search
Menu
Product Program year 2022 Source: CMS Open Payments

Roszet

Drug Cardiovascular

Open in the dashboard

General payments

$78,536

2,967 payments

Research payments

$0

0 payments

Through program year 2022, $78,536 in general payments and $0 in research payments were reported against Roszet (Cardiovascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2022 General $50,273 1,270
2021 General $28,263 1,697

Breakdown

Who paid General payments · program years 2021–2022
  1. Althera Pharmaceuticals LLC $78,536 2,967 payments
Top recipients General payments · program year 2022
  1. John Isaac Interventional Cardiology · Houston, TX $13,726 27% · 9 payments
  2. Isaac Sachmechi Endocrinology, Diabetes & Metabolism · New Hyde Park, NY $4,031 8% · 7 payments
  3. Eric Stocker Cardiovascular Disease · San Antonio, TX $3,996 8% · 6 payments
  4. Ronald Dagostino Cardiovascular Disease · Lake Success, NY $2,776 6% · 11 payments
  5. Meyer Abittan Roslyn, NY $175 <1% · 8 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Interventional Cardiology Internal Medicine $14,869 31% · 40 practitioners
  2. Cardiovascular Disease Internal Medicine $10,007 21% · 105 practitioners
  3. Internal Medicine $5,708 12% · 178 practitioners
  4. Endocrinology, Diabetes & Metabolism Internal Medicine $5,001 10% · 20 practitioners
  5. Family Medicine $4,039 8% · 159 practitioners

The top 5 of 39 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Texas $28,860 57% · 388 recipients
  2. New York $13,748 27% · 101 recipients
  3. New Jersey $4,194 8% · 196 recipients
  4. Oklahoma $3,234 6% · 60 recipients
  5. Pennsylvania $228 <1% · 14 recipients

The top 5 of 6 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

Records

2,967 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record